The detection and measurement of hypoxic cells in solid tumors

Cancer

Volumn 54, Issue 11, 1984, Pages 2441-2449

  Chapman, J D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOSENSITIZING AGENT;

CANCER; CANCER CHEMOTHERAPY; DIAGNOSIS; HUMAN; HUMAN CELL; HYPOXIA; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOTHERAPY; THERAPY;

ANAEROBIOSIS; ANIMAL; ANOXIA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CELL LINE; CELL SURVIVAL; CRICETULUS; HAMSTERS; HUMAN; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MISONIDAZOLE; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RATS; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0021685559     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19841201)54:11<2441::AID-CNCR2820541122>3.0.CO;2-S     Document Type: Article

References (62)

1. Effect of oxygen and nitric oxide on the radiosensitivity of human cells in tissue culture
2. Hypoxic sensitizers: Implications for radiation therapy
3. Potentially three distinct roles for hypoxic cell sensitizers in the clinic
4. In vivo NMR of tumors and normal tissues
5. Labelled pyruvate: A potential agent for imaging hypoxia in tumor (Abstr)
6. The fraction of hypoxic clonogenic cells in tumor populations
7. The histological structure of some human lung cancers and the possible implications for radiotherapy
8. Concentration of oxygen dissolved in tissues at time of irradiation as a factor in radiotherapy
9. Radiotherapy and hyperbaric oxygen in head and neck cancer: Interim report of second clinical trial
10. Radiation and high dose metronidazole in supratentorial glioblastoma
11. Definitive evidence for hypoxic cells influencing cure in cancer therapy
12. Quantitative measurements of oxygen tension in normal tissues and in tumors of patients before and after radiotherapy
13. Effect of oxygen tension of tumors breathing oxygen at high pressures
14. A multicomponent x‐ray survival curve for mouse lymphosarcoma cells irradiated in vivo
15. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis and a survey of existing data
16. The development of radioactive sensitizers as markers for hypoxic cells in tumors
17. Chemical radiosensitization of hypoxic cells
18. Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells
19. Electron affinic sensitization: V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles
20. In vivo testing of hypoxic radiosensitizers using the KHT murine tumor assayed by the lung colony technique
21. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazole metronidazole and Ro‐07‐0582
22. Tests of two electron‐affinic radiosensitizers in vivo using regrowth of an experimental carcinoma
23. Clinical testing of the radiosensitizer Ro‐07‐0582: Experience with multiple doses
24. Clinical phase I study of the hypoxic cell radiosensitizer Ro‐07‐0582, a 2‐nitroimidazole derivative
25. Clinical trials of misonidazole in the United States
26. Clinical trials of hypoxic cell sensitizers
27. Peripheral neuropathy related to misonidazole: Incidence and pathology
28. Measurement of self‐renewal in culture of clonogenic cells from human ovarian carcinoma
29. Selective chemotherapy of non‐cycling cells in an in vitro tumor model
30. Hypoxic sensitizers: Radiobiological studies at the cellular level
31. Hypoxia‐dependent reduction of 1‐(2‐nitro‐1‐imidazole)‐3‐methoxy‐2‐propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo
32. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation
33. Radiation chemical studies with nitrofurazone as related to its mechanism of radiosensitization
34. Radiation‐induced and metabolism induced reactions of hypoxic sensitizers with cellular molecules
35. Intracellular localization of radioactively‐labelled misonidazole in EMT‐6 tumor cells in vitro
36. Characteristics of the metabolism‐induced binding of misonidazole to hypoxic mammalian cells
37. A marker for hypoxic cells in tumors with potential clinical applicability
38. 14C‐Misonidazole to hypoxic cells in V79 spheroids
39. Binding of misonidazole to EMT‐6 and V79 spheroids
40. 14C‐Misonidazole
41. 14C]‐Misonidazole distribution in experimental RT‐9 brain tumors
42. 2 supply conditions
43. 2 saturation in tumor tissue of DS‐carcinoma during normoxia
44. 2 saturation in malignant tumor during normoxia and hyperoxia
45. Tumor oxygenation under normoxic and hyperbaric conditions
46. Intracapillary oxyhemoglobin saturation in malignant tumors in humans
47. Fluorescent nitroheterocycles for identifying hypoxic cells
48. Comparison of oxygen tensions in normal tissues and Yoshida sarcoma of the rat breathing air or oxygen at 4 atmospheres
49. A “thin‐film” culturing technique allowing rapid gas‐liquid equilibration (6 seconds) with no toxicity to mammalian cells
50. Bromomisonidazole: Synthesis and characterization of a new radiosensitizer
51. 82Br]Bromomisonidazole
52. Electron affinic compounds for labelling hypoxic cells: The synthesis and characterization of 1‐[‐2‐(2‐iodophenoxy)‐ethyl]‐2‐nitroimidazole
53. 125I in cell DNA at –196°C
54. Radiation‐induced events and their time scale in mammalian cells
55. The application in radiation therapy of substances which modify cellular radiation response
56. 31P NMR spectroscopy of in vivo tumors
57. Faraday shield for surface‐studies of subcutaneous tumors
58. 31P NMR in athymic mice
59. 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x‐irradiation and hyperthermia
60. 31P NMR of perfused rat hearts
61. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla